4.2 Article

Use of a novel virus detection assay to identify coronavirus HKU1 in the lungs of a hematopoietic stem cell transplant recipient with fatal pneumonia

期刊

TRANSPLANT INFECTIOUS DISEASE
卷 14, 期 1, 页码 79-85

出版社

WILEY-BLACKWELL
DOI: 10.1111/j.1399-3062.2011.00657.x

关键词

viral infections; generic virus detection; virus discovery; immunocompromised; coronavirus; HKU1

资金

  1. Center for Biologics Evaluation and Research
  2. National Institute of Allergy and Infectious Diseases
  3. National Institute of Dental and Craniofacial Research
  4. National Institute of Arthritis and Musculoskeletal and Skin Diseases
  5. National Cancer Institute, and the Centers for Disease Control and Prevention

向作者/读者索取更多资源

A 38-year-old female patient with systemic lupus erythematosus presented with pulmonary infiltrates and hypoxemia for several months following immunodepleting autologous hematopoietic stem cell transplantation. She was treated for influenza, which was isolated repeatedly from oropharynx and bronchoalveolar lavage (BAL) fluids, and later empirically for lupus pneumonitis, but died 6 months after transplant. Autopsy findings failed to show influenza in the lungs or lupus pneumonitis. A novel generic polymerase chain reaction (PCR)-based assay using degenerate primers identified human coronavirus (CoV) HKU1 RNA in BAL fluid at autopsy. CoVwas confirmed by virus-specific PCRs of lung tissue at autopsy. Electron microscopy showed viral particles consistent with CoV HKU1 in lung tissue both at autopsy and from aprevious biopsy. Although human CoV HKU1 infection is not usually severe, in highly immunocompromised patients, it can be associated with fatal pneumonia.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据